Latest Funding Agreements News

Novonix Limited reports significant progress in its synthetic graphite anode materials production, benefiting from new US tariffs on Chinese imports and strategic leadership appointments. The company also secures up to US$100 million in convertible debenture funding to support expansion plans.

NOVONIX has entered a multi-tranche funding agreement with Yorkville Advisors to raise up to US$100 million through convertible debentures, supporting its Riverside facility build-out and commercial production ramp-up.

Volt Resources has drawn $0.5 million from a $1 million funding agreement to accelerate development of its graphite projects in Tanzania and the US, positioning itself amid rising US tariffs on Chinese graphite imports.

Kinterra Infrastructure has increased its takeover offer for New World Resources shares to A$0.063, with a potential rise to A$0.064 if it secures over 30% ownership. This move intensifies the takeover battle against rival CAML, promising quicker payments and stronger funding assurances.

Universal Biosensors has signed a non-binding term sheet for an A$8.5 million senior secured loan with Viburnum Funds, alongside plans for an equity raising. The move comes with governance shifts, including a director resignation to avoid conflicts.

Spenda Limited has partnered with APG Pay to develop a closed-loop corporate credit platform, backed by a $50 million funding commitment, aiming to transform B2B payments across multiple industries starting with corporate travel.

Argenica Therapeutics has won up to $1.5 million in non-dilutive government funding to support its late-stage clinical trial of ARG-007, a promising treatment for acute ischaemic stroke.

Emyria has landed a multi-year funding deal with Medibank to support its Empax PTSD program at Perth Clinic, marking a first for private insurer-backed psychotherapy in Australia. The company also announces a $4 million capital raise to fuel national expansion.

Sumitomo Corporation's subsidiary has gained crucial Foreign Investment Review Board approval to invest in Tivan Limited's Speewah Fluorite Project, paving the way for a significant joint venture.

Dateline Resources secures high-level U.S. government endorsement for its Colosseum Rare Earths Project, highlighting its strategic role in domestic critical minerals supply. The project’s significant gold resources and rare earth potential position it as a key player in America’s mineral independence efforts.

Opthea Limited faces a pivotal moment as four board members resign following disappointing Phase 3 trial results and a major workforce reduction. The company’s future hinges on ongoing funding negotiations amid trading suspensions.

Toys"R"Us ANZ Limited reported a significant increase in product margins and sales revenue despite inventory challenges, while advancing a recapitalisation plan to secure its financial future.